Plain-English translation of NCT07641582 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are developing a new way to predict atrial fibrillation—a condition where the heart beats irregularly—by combining genetic testing with heart monitoring over one year. This study will help doctors identify people most at risk for this condition before symptoms become serious, potentially preventing strokes and other complications.
Atrial fibrillation often goes undetected because symptoms come and go, making it hard to catch early. This trial aims to find a better screening approach using genetic information to identify who needs closer heart monitoring, so treatment can start sooner.
You likely qualify if…
You likely don't qualify if…
At the start, you'll have a blood sample collected for genetic testing and wear a continuous heart monitor patch for 7 days, plus receive a standard heart tracing (ECG). Then, for one year, you'll use a small portable heart monitor device at home to record your heart rhythm at least once or twice weekly, and extra times if you notice symptoms. At the end of the year, researchers will analyze your genetic data and heart recordings to develop a tool that could help predict atrial fibrillation risk in others.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
South Korea